Enrichment analysis of genes from the significant MS module. حسب Lai Jiang (2401513)

الموضوعات:

IFA significantly attenuated capsule-mediated resistance to the binding of C3b and C5b-9 to bacterial surface. حسب Tingting Wang (123983)

الموضوعات:

Schematic diagram of the molecular mechanism by which TRIM37 improves MS by stabilizing PEX5 through monoubiquitination. حسب Lai Jiang (2401513)

الموضوعات:

Sobel test for the significance of the mediation effect. حسب Getachew Magnar Kitila (19935139)

AdMSC-EVs enhanced colony formation and migration of LECs and decreased proliferation. حسب Xiaoqin Li (1399105)

الموضوعات:

Encapsulation efficiency significantly decreases with increasing starting bacterial concentration. حسب Kelly C. Freudenberger Catanzaro (6701789)

DICER protein expression is significantly decreased in the absence of MOV10 and FMRP. حسب Monica C. Lannom (11772729)

Transepithelial resistance of NHBE decreases significantly after PAA exposure. حسب Ellie S. Burns (21246537)

Thymus regeneration promotes naïve T-cell recovery in iMycTg aging-E mice and a partial decrease in Treg frequencies. حسب Abigail Morales-Sánchez (21799582)

الموضوعات:

CRISPR-Cas9-mediated mutation analysis of T₀ Stmc7 mutants. حسب Bikram Poudel (15989201)

الموضوعات:

Amalgamation of plasma complement proteins with classical biomarkers significantly improved the stratification of Alzheimer's disease حسب Liming Shen (8533629)

Lymphocytes decreased in mouse pneumonia model. حسب Qi Xu (134661)

الموضوعات:

Cabozantinib significantly decreases tumor volume and prolongs survival in SCNPC PDX models. حسب Mark P. Labrecque (10011469)

Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"